SCHEDULE: Vanguard Group Reports Zero Beneficial Ownership in Teradyne

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Teradyne Inc. following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 17 to Schedule 13G for Teradyne Inc. Common Stock, CUSIP 880770102.
• The filing reports 0% aggregate beneficial ownership of Teradyne Inc. Common Stock by The Vanguard Group.
• This change follows an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• As a result of the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these disaggregated subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily a procedural update regarding The Vanguard Group's internal reporting structure rather than a change in investment thesis or a significant event for Teradyne Inc.

Future Outlook

Following an internal realignment on January 12, 2026, The Vanguard Group's subsidiaries and business divisions will now report their beneficial ownership of securities separately, disaggregated from The Vanguard Group, Inc.

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment.
• Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

Industry Context

StockSavvy.ai notes that such internal realignments and subsequent disaggregated reporting are common among large institutional investors like The Vanguard Group, often driven by operational efficiencies, regulatory compliance, or strategic shifts in fund management structures. This particular filing reflects a procedural change in how Vanguard reports its holdings rather than a change in its overall investment strategy or a divestment from Teradyne by its underlying funds.

Stakeholder Impact

• Shareholders of Teradyne Inc. will see The Vanguard Group's direct beneficial ownership reported as 0%, with underlying holdings now reported by Vanguard's disaggregated subsidiaries.
• Investors tracking institutional ownership will need to consider filings from Vanguard's subsidiaries for a complete picture of Vanguard's overall exposure to Teradyne.

Next Steps

• Vanguard's subsidiaries and business divisions will report their beneficial ownership separately in future filings.

Key Dates

Keywords

Teradyne Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Ownership, Common Stock, Investment Adviser, Corporate Realignment